Literature DB >> 26511948

Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes.

Giuseppe Bellastella1, Maria Ida Maiorino2, Annamaria De Bellis3, Maria Teresa Vietri4, Carmela Mosca2, Lorenzo Scappaticcio2, Daniela Pasquali3, Katherine Esposito5, Dario Giugliano2.   

Abstract

Diurnal salivary and plasma cortisol variations are considered valid expression of circadian cortisol rhythmicity. The aim of this study was to assess the reliability of salivary and plasma cortisol and if glycemia and glycemic oscillations may interfere with their concentration. Forty-seven type 2 diabetic patients and 31 controls were studied for glycemic profile and diurnal salivary and plasma cortisol variations on two contemporary samples taken at 08:00 a.m.-11:00 p.m (Late Night, LN). Glucose variability was evaluated in diabetic patients by considering the standard deviation of blood glucose (BGSD) readings, by calculating the mean amplitude of glycemic excursions (MAGEs) and continuous overlapping net glycemic action (CONGA). A significant correlation between LN serum cortisol and morning fasting glycemia (r = 0.78; p = 0.004) was observed in T2DM group but not in the control group (r = 0.09; p = 0.74). While LN serum cortisol significantly correlated with CONGA in diabetic patients (r = 0.50; p < 0.001), LN salivary cortisol did not correlate with any indices of glucose variability. Moreover, a highly significant correlation between LN salivary and LN serum cortisol concentrations was found in control group (r = 0.80; p < 0.001) but not in diabetic patients (r = 0.07; p = 0.62). This study shows for the first time that LN salivary rather than plasma cortisol may give information on the dynamics of adrenal function of type 2 diabetic patients, as it is not significantly influenced by glycemic variations. However, our preliminary results need to be confirmed by further studies with more complete evaluations including many more patients.

Entities:  

Keywords:  Glycemic variability; Salivary cortisol; Serum cortisol; Type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26511948     DOI: 10.1007/s12020-015-0777-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

Review 1.  Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing's syndrome?

Authors:  Therese Krarup; Thure Krarup; Claus Hagen
Journal:  Diabetes Metab Res Rev       Date:  2012-03       Impact factor: 4.876

Review 2.  Diagnosis and complications of Cushing's syndrome: a consensus statement.

Authors:  G Arnaldi; A Angeli; A B Atkinson; X Bertagna; F Cavagnini; G P Chrousos; G A Fava; J W Findling; R C Gaillard; A B Grossman; B Kola; A Lacroix; T Mancini; F Mantero; J Newell-Price; L K Nieman; N Sonino; M L Vance; A Giustina; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

3.  Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients.

Authors:  Iacopo Chiodini; Massimo Torlontano; Alfredo Scillitani; Maura Arosio; Simonetta Bacci; Sergio Di Lembo; Paolo Epaminonda; Giovanni Augello; Riccardo Enrini; Bruno Ambrosi; Guido Adda; Vincenzo Trischitta
Journal:  Eur J Endocrinol       Date:  2005-12       Impact factor: 6.664

Review 4.  Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2013-07-10       Impact factor: 3.633

Review 5.  Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes.

Authors:  J Smith-Palmer; M Brändle; R Trevisan; M Orsini Federici; S Liabat; W Valentine
Journal:  Diabetes Res Clin Pract       Date:  2014-06-23       Impact factor: 5.602

Review 6.  Pitfalls in the diagnosis and management of Cushing's syndrome.

Authors:  Vivek Bansal; Nadine El Asmar; Warren R Selman; Baha M Arafah
Journal:  Neurosurg Focus       Date:  2015-02       Impact factor: 4.047

7.  Late-night salivary cortisol as a screening test for Cushing's syndrome.

Authors:  H Raff; J L Raff; J W Findling
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

8.  Defining adrenal status with salivary cortisol by gold-standard insulin hypoglycemia.

Authors:  Matthew S Karpman; Madalina Neculau; Valerian C Dias; Gregory A Kline
Journal:  Clin Biochem       Date:  2013-05-14       Impact factor: 3.281

9.  Cushing's syndrome in type 2 diabetes patients with poor glycemic control.

Authors:  Askin Gungunes; Mustafa Sahin; Taner Demirci; Bekir Ucan; Evrim Cakir; Muyesser Sayki Arslan; Ilknur Ozturk Unsal; Basak Karbek; Mustafa Calıskan; Mustafa Ozbek; Erman Cakal; Tuncay Delibasi
Journal:  Endocrine       Date:  2014-04-17       Impact factor: 3.633

10.  A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.

Authors:  J Newell-Price; P Trainer; L Perry; J Wass; A Grossman; M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1995-11       Impact factor: 3.478

View more
  9 in total

1.  Is the hypothalamic-pituitary-adrenal axis disrupted in type 2 diabetes mellitus and is this relevant for bone health?

Authors:  Cristina Eller-Vainicher; Alfredo Scillitani; Iacopo Chiodini
Journal:  Endocrine       Date:  2017-01-28       Impact factor: 3.633

2.  Is the hypothalamic-pituitary-adrenal axis disrupted in type 2 diabetes mellitus?

Authors:  Hershel Raff; Steven B Magill
Journal:  Endocrine       Date:  2016-09-30       Impact factor: 3.633

3.  Individual differences in glucocorticoid regulation: Does it relate to disease risk and resilience?

Authors:  Jasmine I Caulfield; Sonia A Cavigelli
Journal:  Front Neuroendocrinol       Date:  2019-11-04       Impact factor: 8.606

Review 4.  Diabetes in Cushing Disease.

Authors:  G Mazziotti; A M Formenti; S Frara; F Maffezzoni; M Doga; A Giustina
Journal:  Curr Diab Rep       Date:  2017-05       Impact factor: 4.810

5.  Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis.

Authors:  Elias K Spanakis; Xu Wang; Brisa N Sánchez; Ana V Diez Roux; Belinda L Needham; Gary S Wand; Teresa Seeman; Sherita Hill Golden
Journal:  Endocrine       Date:  2016-02-19       Impact factor: 3.633

6.  Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease.

Authors:  Luisa Albanese; Gemma Caliendo; Giovanna D'Elia; Luana Passariello; Anna Maria Molinari; Claudio Napoli; Maria Teresa Vietri
Journal:  J Circ Biomark       Date:  2022-01-08

Review 7.  Glucocorticoid Receptor Signaling in Diabetes.

Authors:  Ioanna Kokkinopoulou; Andriana Diakoumi; Paraskevi Moutsatsou
Journal:  Int J Mol Sci       Date:  2021-10-16       Impact factor: 6.208

8.  Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.

Authors:  Maria Teresa Vietri; Giovanna D'Elia; Gemma Caliendo; Luisa Albanese; Giuseppe Signoriello; Claudio Napoli; Anna Maria Molinari
Journal:  Genes (Basel)       Date:  2022-02-09       Impact factor: 4.096

9.  Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection.

Authors:  Maria Teresa Vietri; Giovanna D'Elia; Gemma Caliendo; Luana Passariello; Luisa Albanese; Anna Maria Molinari; Italo Francesco Angelillo
Journal:  Vaccine       Date:  2022-08-26       Impact factor: 4.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.